Chewy Stock Dips As Guidance Cut Overshadows Strong Q1 Beat

Chewy Inc. stocks have been trading up by 3.09 percent amid upbeat pet spending trends and strengthening online demand.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading CHWY

JOIN 50,000+ ACTIVE TRADERS

What Traders Need To Know

Q1 FY2026 net sales rose 7.7% year over year to $3.36B, with gross margin at 30.1% and net income up 51.9% as net margin reached 2.8%.
Adjusted EBITDA grew 31% with margin at 7.5%, free cash flow hit $70.8M, active customers climbed to 21.5M, and Autoship penetration reached 84.4% of net sales.
Management called Q1 “solid” with roughly 170,000–200,000 net new customers and higher spend per customer but guided FY2026 conservatively as the pet consumer weakens.
Fiscal 2026 sales guidance was trimmed on softer pet-category demand and higher fuel costs, pressuring the stock despite stable EBITDA margin guidance.
Major banks cut price targets but kept Buy/Overweight ratings, pointing to ongoing share gains, durable margin expansion, and upside once demand normalizes.

Weekly Update Jun 08 – Jun 12, 2026: On Friday, June 12, 2026 Chewy Inc. stock [NYSE: CHWY] is trending up by 3.09%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Consumer Discretionary industry expert:

Analyst sentiment – positive

Chewy holds a leading share in US online pet supplies, with $12.6B TTM revenue growing high single digits and gross margin near 30%. EBIT margin at 2.5% and ROIC above 25% show a now-scalable model despite thin net margin (~2%). Cash conversion is improving: Q1 free cash flow of $71M on $109M operating cash flow, even after working-capital drag. Balance sheet is tight (current ratio 0.8, negative working capital) but interest coverage >100x limits financial risk.

Technically, CHWY is consolidating after a sharp post-earnings move: this week’s range ran roughly $18.75–$20.8 with a slight higher-low, higher-close bias versus the recent sub‑$18 base. Intraday 5‑minute action shows liquidity building around $19.00–$19.25 as a volume node and buyer support. Dominant trend on the weekly remains early-stage recovery within a larger downtrend. Tactically, $19.00 is the actionable pivot: buy strength above with a stop below $18.70.

More Breaking News

Near term, the market is punishing Chewy’s guidance reset despite record profitability, but the fundamental trajectory remains superior to Consumer Discretionary and Retail–Discretionary peers: faster revenue, expanding margins, and growing recurring Autoship and health-care exposure. Street targets in the low‑30s to mid‑40s imply substantial upside from ~$20. Key catalysts: integration of Modern Animal, vet clinic rollout, and AI-driven efficiencies from 2027. My 12‑month fair value is $30–32, with support at $18 and resistance at $25.

Quick Financial Overview

Chewy Inc. (CHWY) just printed a fundamentally strong Q1 FY2026. Net sales grew 7.7% year over year to $3.36B, with gross margin up to 30.1% and net income jumping 51.9%, pushing net margin to 2.8%. Adjusted EBITDA rose 31% and margin reached 7.5%, while free cash flow improved 45% to $70.8M. For traders, that combination of growth, margin expansion, and cash generation shows a business getting more efficient even in a soft consumer backdrop.

Customer metrics back that up. Active customers increased 3.6% to 21.5M and Autoship sales grew 10.5%, now 84.4% of net sales, underscoring the sticky, recurring revenue engine that Chewy Inc. leans on. Management says CHWY is gaining market share and expects to grow at roughly twice the pet market, while building out pet healthcare, including the Modern Animal acquisition and a plan to operate about 60 veterinary clinics by end of 2026.

On valuation, CHWY screens like a profitable growth name: trailing revenue of about $12.6B with a price-to-sales near 0.82 and a P/E around 41.5. Margins are still thin, but profitability ratios are improving, with return on equity high and asset turnover strong. The balance sheet shows negative working capital and a current ratio under 1, plus notable leverage, so traders should respect liquidity risk if macro conditions worsen.

From the tape, the weekly data show CHWY fading from a recent high near $20.80 down toward $18.88 before bouncing back around $19.31. That’s a mild pullback after a strong pre-earnings run, consistent with “good numbers, cautious guide” profit-taking. Intraday, the latest session carved out a tight intraday range roughly between $18.35 and $19.35 with a firm close near $19.28–$19.31, signaling dip buyers stepping in around the mid-$18s.

Conclusion

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.

Start Your Trial Now!